Lysophosphatidylcholines are a group of bioactive lipids heavily investigated in the context
of inflammation and atherosclerosis development. While present in plasma during …

Liquid biopsy, a noninvasive diagnosis that examines circulating tumor components in body
fluids, is increasingly used in cancer management. An overview of relevant literature …

Changes in plasma and fecal metabolomes in colorectal cancer (CRC) progression (normal-
adenoma-CRC) remain unclear. Here, plasma and fecal samples were collected from four …

Background Amino acid metabolism is dysregulated in colorectal cancer patients; however,
it is not clear whether pre-diagnostic levels of amino acids are associated with subsequent …

Aberrant tumor metabolism is a hallmark of cancer in which metabolic rewiring can support
tumor growth under nutrient deficient conditions. KRAS mutations occur in 35–45% of all …

The application of rapid and accurate diagnostic methods can improve colorectal cancer
(CRC) survival rates dramatically. Here, we used a non-targeted metabolic analysis strategy …

Abstract Background Approximately 95% of Colorectal cancers (CRC) consist of
adenocarcinomas originating from colonic Adenomatous polyps (AP). Increasing importance …

Dysregulation of tryptophan metabolism has been linked to colorectal tumorigenesis;
however, epidemiological studies investigating tryptophan metabolites in relation to …

Background The morbidity of cancer keeps growing worldwide, and among that, the
colorectal cancer (CRC) has jumped to third. Existing early screening tests for CRC are …

Zearalenone (ZEA), a secondary metabolite of Fusarium fungi found in cereal-based foods,
promotes the growth of colon, breast, and prostate cancer cells in vitro. However, the lack of …